Physiology and pharmacology of chronic diseases
FIFAEC
University of Antwerp
Amberes, BélgicaPublications in collaboration with researchers from University of Antwerp (4)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2008
-
2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: Design, synthesis, and SAR studies
Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 2, pp. 793-797
2006
-
Pyridazines part 41: Synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl) pyridazin-3(2H)-ones
Bioorganic and Medicinal Chemistry Letters, Vol. 16, Núm. 4, pp. 1080-1083
1990
-
Asymmetric distribution of calbindin-D28K in the ganglia habenulae of an elasmobranch fish
Anatomy and Embryology, Vol. 181, Núm. 4, pp. 389-391